Lars Wallentin
Uppsala University Hospital
Internal medicineSurgeryTroponin TCardiologyIntensive care medicineST segmentST elevationHeparinAcute coronary syndromeUnstable anginaCoronary artery diseaseAnginaChest painRevascularizationElectrocardiographyFibrinolytic agentIn patientTroponinMyocardial infarctionMedicine
Publications 83
#1Eliano Pio Navarese (UMK: Nicolaus Copernicus University in Toruń)H-Index: 34
#2Safi U. Khan (WVU: West Virginia University)H-Index: 16
Last. Stefan James (Uppsala University Hospital)H-Index: 96
view all 15 authors...
Background: New randomized controlled trials (RCTs) have become available on oral P2Y12 inhibitors in acute coronary syndrome (ACS). We aimed to evaluate current evidence comparing the efficacy and...
28 CitationsSource
#1Wael Sumaya (University of Sheffield)H-Index: 8
#2Lars WallentinH-Index: 30
Last. Robert F. Storey (University of Sheffield)H-Index: 90
view all 8 authors...
#1David Erlinge (Lund University)H-Index: 75
#2Elmir Omerovic (Sahlgrenska University Hospital)H-Index: 36
Last. Stefan James (Uppsala University Hospital)H-Index: 96
view all 39 authors...
BACKGROUND The comparative efficacy of various anticoagulation strategies has not been clearly established in patients with acute myocardial infarction who are undergoing percutaneous coronary inte ...
149 CitationsSource
#1Michael J. Lipinski (MedStar Washington Hospital Center)H-Index: 33
#2Michael A. Gaglia (MedStar Washington Hospital Center)H-Index: 21
Last. Ron Waksman (MedStar Washington Hospital Center)H-Index: 98
view all 12 authors...
Little is known regarding the ability of ticagrelor to inhibit platelet reactivity in African Americans (AA) with acute coronary syndrome (ACS). Thus, we performed pharmacodynamic studies of platelet reactivity following treatment with ticagrelor in AA with ACS. We prospectively enrolled AA with
#1Wobo Bekwelem (UMN: University of Minnesota)H-Index: 7
#2Stuart J. Connolly (McMaster University)H-Index: 140
Last. Alan T. Hirsch (UMN: University of Minnesota)H-Index: 76
view all 12 authors...
Background Nonvalvular atrial fibrillation is a major cause of thromboembolic events. In comparison with atrial fibrillation-related stroke, extracranial systemic embolic events (SEEs) remain poorl ...
56 CitationsSource
#1R. A. H. StewartH-Index: 4
#2Paul W. ArmstrongH-Index: 12
Last. Harvey D. WhiteH-Index: 144
view all 10 authors...
Effect of ivabradine on heart rate variability in patients with stable coronary artery disease
#1Joakim Alfredsson (Linköping University)H-Index: 21
#2Tim Clayton (Lond: University of London)H-Index: 58
Last. Eva Swahn (Linköping University)H-Index: 51
view all 9 authors...
Background A routine invasive (RI) strategy in non-ST-segment elevation acute coronary syndromes (NSTE ACS) has been associated with better outcome compared with a selective invasive (SI) strategy ...
11 CitationsSource
#1John D. Horowitz (University of Adelaide)H-Index: 72
#2R. De CaterinaH-Index: 32
Last. Lars Wallentin (Uppsala University Hospital)H-Index: 30
view all 10 authors...
ADMA and SDMA predict outcomes in patients with chronic atrial fibrillation : an ARISTOTLE substudy
4 CitationsSource
#1Robert F. Storey (University of Sheffield)H-Index: 90
#2Philippe Steg (University of Sheffield)H-Index: 7
Last. Lars Wallentin (University of Sheffield)H-Index: 30
view all 10 authors...
2 CitationsSource
#1Imre Janszky (KI: Karolinska Institutet)H-Index: 50
#2Staffan Ahnve (KI: Karolinska Institutet)H-Index: 42
Last. Ulf StenestrandH-Index: 35
view all 7 authors...
Abstract Background Daylight saving time shifts can be looked upon as large-scale natural experiments to study the effects of acute minor sleep deprivation and circadian rhythm disturbances. Limited evidence suggests that these shifts have a short-term influence on the risk of acute myocardial infarction (AMI), but confirmation of this finding and its variation in magnitude between individuals is not clear. Methods To identify AMI incidence on specific dates, we used the Register of Information ...
53 CitationsSource